Medical News

RSS

AHF applauds Gilead for offering pricing, access concessions to AIDS Drug Assistance Programs

AIDS Healthcare Foundation (AHF) lauded Gilead Sciences, maker of several key AIDS drugs, for its announcement earlier today that it will offer significant pricing and access concessions for the nation's beleaguered AIDS Drug Assistance Programs (ADAPs), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need.

5 Jun 2010

AMA launches ads pushing Senators on 'doc fix' while warning on cuts

The American Medical Association has launched a multi-million-dollar series of ads pressuring senators to intervene to prevent a scheduled payment cut for doctors who treat Medicare patients and warning that a separate permanent fix of the system is the only way to completely ensure continuity of care for seniors.

5 Jun 2010

Walter Reed Army Medical Center to treat pain patients with CTT's Calmare Pain Therapy Treatment

Competitive Technologies, Inc. announced today that the Walter Reed Army Medical Center in Washington, D.C., has joined the growing list of organizations that will treat pain patients with CTT's Calmare Pain Therapy Treatment, as authorized by the Surgeon General of the U.S. Army and Commanding General of the U.S. Army Medical Command.

5 Jun 2010

Biomet Biologics initiates enrollment in MarrowStim P.A.D. Kit IDE trial for critical limb ischemia

Biomet, a global leader in the manufacture of orthopedic and biotechnology products, announced today that its subsidiary, Biomet Biologics, has enrolled the first subject into its multicenter, prospective, randomized, double-blind, placebo-controlled clinical trial for critical limb ischemia (CLI).

5 Jun 2010

Boston hospitals increasingly scrutinized for costs while Buffalo hospitals will receive more Medicare funding

Officials in Gov. Deval Patrick's administration, "seeking to pressure hospitals as well as insurers to rein in costs, say they will more closely scrutinize plans for new medical buildings and technologies to determine how they might affect the cost of health care in Massachusetts.

5 Jun 2010

Amity Foundation awarded $1,000,000 grant to build Dragonfly Village for children and families

The Federal Home Loan Bank of San Francisco, California has awarded Amity Foundation a $1,000,000 grant to help build Dragonfly Village, a state-of-the-art center for children and families at Amity Foundation's Circle Tree Ranch in Tucson, Arizona.

5 Jun 2010

Coffee consumption not related to alertness

The stimulatory effects of caffeine may be nothing more than an illusion according to new research, which shows there is no real benefit to be gained from the habitual morning cup of coffee.

4 Jun 2010

Too much weight in pregnancy may lead to future heart risks in offspring

Researchers have uncovered evidence to show that piling on too many pounds in pregnancy may lead to future heart risks in the child.

4 Jun 2010

High frequency ventilation for preterm babies just as effective

A University of Sydney study of ventilation strategies has shown that high-frequency oscillatory ventilation (HFOV) for preterm babies gives the same outcomes as conventional ventilation (CV).

4 Jun 2010

Cardinal Health and UW collaborate to advance use of molecular imaging in clinical investigations and trials

Cardinal Health and the University of Washington (UW) today announced an innovative public-private collaboration designed to advance the use of molecular imaging in clinical investigations and trials.

4 Jun 2010

Ascenta Therapeutics, sanofi-aventis sign global licensing agreement for cancer drug candidates

Ascenta Therapeutics announced today the signing of a global collaboration and licensing agreement with sanofi-aventis covering several early-stage agents being investigated for their potential to restore tumor cell apoptosis (programmed cell death). These orally-active, small-molecule drug candidates inhibit the interaction between HDM2 (Human Double Minute 2) and p53, removing a block to normal p53 tumor suppressor function and potentially enhancing cancer control and treatment.

4 Jun 2010

Bayer to present Phase I and II clinical trial data of Alpharadin in CRPC at 46th ASCO

Bayer HealthCare will present a combined analysis from Phase I and II clinical trials evaluating the safety and efficacy of one of its lead investigational cancer treatments, Alpharadin™ (radium-223 chloride), in castration-resistant prostate cancer (CRPC) that has spread to the bones (metastases).

4 Jun 2010

Vivakor reduces long and short term debt

Vivakor, Inc. today announced the Company has reduced its long and short term debt by an additional $510,000 by converting those debts to shares of common stock. This substantial debt reduction through conversion to stock finalizes the acquisition payments for Health America Inc. and the VIVASLICES MRI software technology, which the company purchased in August of 2008.

4 Jun 2010

Nile Therapeutics receives Nasdaq non-compliance notice

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that, on June 1, 2010, the Company received a letter from The Nasdaq Stock Market indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, Nile was not in compliance with Marketplace Rule 5550(a)(2).

4 Jun 2010

Novartis cancels Emisphere Technologies' Convertible Promissory Note

Emisphere Technologies, Inc. today announced that it has entered into an expanded relationship with Novartis Pharma AG pursuant to which Novartis has cancelled the Company's Convertible Promissory Note. The Note was originally issued to Novartis on December 1, 2004 in connection with the Research Collaboration and Option License Agreement between the parties of that date and was originally due December 1, 2009. Previously, Novartis had agreed to extend the maturity date to June 4, 2010.

4 Jun 2010

Infinity announces Phase 2 clinical trial results of IPI-504 for NSCLC

Infinity Pharmaceuticals, Inc. today reported the results from its Phase 2 clinical trial of IPI-504, the company's i.v.-administered Hsp90 chaperone inhibitor, in patients with advanced non-small cell lung cancer (NSCLC). Data reported show that IPI-504 demonstrated clinical activity in patients with NSCLC, in particular among patients with oncogenic anaplastic lymphoma kinase (ALK) gene rearrangements.

4 Jun 2010

Ascalon International signs license agreement with CerRx

Ascalon International Inc., a newly established oncology drug developer, today announced an agreement for an exclusive option to license CerRx Inc's intravenous fenretinide product.

4 Jun 2010

BioSpecifics' board authorizes $2 million common stock repurchase program

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its Board of Directors has authorized the repurchase of up to $2 million of its outstanding common stock. This decision reflects the Company's continued commitment to increasing value for its stockholders and its confidence that it will achieve its goals.

4 Jun 2010

TeleTracking Technologies, Sodexo announce multi-year renewal of sales partnership

TeleTracking Technologies and Sodexo, Inc. today announced a multi-year renewal of their long-standing sales partnership to bring automated patient flow and transport solutions to hospitals.

4 Jun 2010

Earliest blood flow begins all at once

By capturing movies of both the blood and vasculature of zebrafish embryos, each less than two millimeters long, researchers have been able for the first time to see the very moment that blood begins to flow.

4 Jun 2010

Medical News

AHF applauds Gilead for offering pricing, access concessions to AIDS Drug Assistance Programs

AMA launches ads pushing Senators on 'doc fix' while warning on cuts

Walter Reed Army Medical Center to treat pain patients with CTT's Calmare Pain Therapy Treatment

Biomet Biologics initiates enrollment in MarrowStim P.A.D. Kit IDE trial for critical limb ischemia

Boston hospitals increasingly scrutinized for costs while Buffalo hospitals will receive more Medicare funding

Amity Foundation awarded $1,000,000 grant to build Dragonfly Village for children and families

Coffee consumption not related to alertness

Too much weight in pregnancy may lead to future heart risks in offspring

High frequency ventilation for preterm babies just as effective

Cardinal Health and UW collaborate to advance use of molecular imaging in clinical investigations and trials

Ascenta Therapeutics, sanofi-aventis sign global licensing agreement for cancer drug candidates

Bayer to present Phase I and II clinical trial data of Alpharadin in CRPC at 46th ASCO

Vivakor reduces long and short term debt

Nile Therapeutics receives Nasdaq non-compliance notice

Novartis cancels Emisphere Technologies' Convertible Promissory Note

Infinity announces Phase 2 clinical trial results of IPI-504 for NSCLC

Ascalon International signs license agreement with CerRx

BioSpecifics' board authorizes $2 million common stock repurchase program

TeleTracking Technologies, Sodexo announce multi-year renewal of sales partnership

Earliest blood flow begins all at once

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News